header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

POLYETHYLENE CROSSLINKING REDUCES WEAR IN TOTAL KNEE ARTHROPLASTY



Abstract

Polyethylene wear is a significant factor limiting survivorship of total knee arthroplasty (TKR). Crosslinking of polyethylene has been shown to significantly reduce wear in hip arthroplasty but has not been reported for TKR. This study measured wear in polyethylene cross-linked to two levels in a knee wear simulator.

Six polyethylene knee inserts were tested in a knee wear simulator. Inserts were manufactured from polyethylene crosslinked to two different levels: 2.5 Mrad (Low-X) and 10.5 Mrad (High-X). Each implant was enclosed in a closed lubricant (50% alpha fraction calf serum) recirculation chamber, maintained at 37°C and changed every 500,000 cycles. Physiologic levels of load and motion were applied at 1 Hz for a total of 6,000,000 cycles. Wear was measured by the gravimetric method before wear testing and at every 500,000 cycles. Semi-quantitative wear assessment was performed by imaging the insert surfaces at 10x magnification.

The Low-X inserts demonstrated significantly higher wear rates (mean 4.66 mg/million cycles) than the High-X inserts (mean 1.55 mg/million cycles, p < 0.001). Wear scars on the Low-X inserts were irregular and visibly deeper than those on the High-X inserts. The machining marks on the surface of the insert were also better preserved in the High-X insert wear scars. These results suggest that crosslinked PE can significantly reduce wear in TKR under physiologic conditions. This can result in reduced lysis and increased survivorship. Localized damage can cause catastrophic failure in polyethylene knee inserts. Therefore, further studies are necessary to evaluate wear under these conditions.

The abstracts were prepared by Nico Verdonschot. Correspondence should be addressed to him at Orthopaedic Research Laboratory, University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.